Regulatory reports
LATEST ALERTS
-
Australia Research looks at opportunities for growth in cannabis sector… - Italy Vague decree on medical cannabis enters into force…
- Argentina Framework for hemp and medical cannabis in effect…
- Costa Rica Full regulation still awaited as licence requirement ends…
- California - United States Vets may be allowed to recommend cannabis for pets…
- California - United States Labelling and packaging bill moves forward…
- Connecticut - United States State’s cannabis rules amended…
- Rhode Island - United States Recreational cannabis possession and sale legalised…
- United States - Vermont CBD and delta-8 control placed in cannabis board hands…
- Canada Cannabis products recalled over inaccurate labels…
- Rhode Island - United States Bills to legalise recreational cannabis passed…
- New York - United States Arrests made over delta-8 sales…
Regulatory report: Netherlands, February 2021
Written by Dmytro Korchahin || 15th February 2021 || Regulatory reports |
The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD ...
Regulatory report: Canada, February 2021
Written by Anthony Traurig || 8th February 2021 || Regulatory reports |
Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules ...
Regulatory report: interstate shipping of CBD and hemp in the US
Written by Anthony Traurig || 25th January 2021 || Regulatory reports |
This report examines the current rules for US interstate transportation, covering documentation needed as well as individual courier rules ...
CBD product labelling – a US state-by-state analysis
Written by Anthony Traurig || 14th January 2021 || Regulatory reports , Regulatory trackers |
This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states' regulations as possible ...
Regulatory report: Philippines, January 2021
Written by Elsa Carrasco || 13th January 2021 || Regulatory reports |
A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the...
Regulatory report: North Macedonia, January 2021
Written by CBD-Intel || 11th January 2021 || Regulatory reports |
Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework ...
Regulatory report: Cyprus, December 2020
Written by CBD-Intel || 15th December 2020 || Regulatory reports |
CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place ...
Regulatory report: the implications of the Kanavape case on CBD in the EU
Written by Anthony Traurig || 14th December 2020 || Regulatory reports |
The implications of the Kanavape ruling could be far-reaching. This report examines the decision by the Court of Justice of the European Union (CJEU) and some of its likely consequences ...
Regulatory report: Ecuador, December 2020
Written by Lenka Hajnovicova || 10th December 2020 || Regulatory reports |
This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis ...
Regulatory report: Ireland, December 2020
Written by Elsa Carrasco || 9th December 2020 || Regulatory reports |
Cannabis, THC and CBN are controlled substances in Ireland under the Misuse of Drugs Act, but CBD and CBG are not. This report offers an overview of the current regime in Ireland ...
Regulatory report: CBD in cosmetics – a US state-by-state report
Written by Anthony Traurig || 2nd December 2020 || Regulatory reports |
Cosmetics have been a mainstay in the CBD market in the US, and there are no signs that is likely to change any time soon. This report offers an overview of the current status of CBD in cosmetics...
Regulatory report: Italy, November 2020
Written by Lorenzo Guaragna || 16th November 2020 || Regulatory reports |
The Italian regulatory landscape differentiates between hemp and cannabis. This report offers a detailed overview of the current regime for CBD as well as for medical and recreational cannabis ...
CBD in dietary supplements: alternative pathways to market under the US FDA
Written by Anthony Traurig || 12th November 2020 || Regulatory reports |
The US Food and Drug Administration (FDA) may be open to allowing CBD as an ingredient in dietary supplements as well as in food and drink products. However, the regulatory pathway is not clear ...
Regulatory report: Singapore, November 2020
Written by Tao Hong || 9th November 2020 || Regulatory reports |
Singapore has a tough regime for hemp products. This report offers an overview of said regime, covering all areas of law ...
Regulatory report: where can cannabis and CBD be bought in Canada?
Written by Pablo Cano Trilla || 6th November 2020 || Regulatory reports |
This report provides an overview of the recreational cannabis and CBD market in Canada in relation to the provincial regulations in place across the country ...
Regulatory report: Greece, November 2020
Written by Elsa Carrasco || 5th November 2020 || Regulatory reports |
There is currently no specific national legislation in Greece relating to CBD, nor are there any restrictions that could prohibit the sale and import of CBD isolates, provided that the CBD source complies with relevant laws ...
Regulatory report: courses of action for proposed US DEA hemp measures
Written by Anthony Traurig || 4th November 2020 || Regulatory reports |
The US Drug Enforcement Administration (DEA)’s new Interim Federal Rule on hemp has many in the industry concerned. There are potential solutions that could allay many industry fears, and this report outlines a few ...
Regulatory report: Australia, October 2020
Written by CBD-Intel || 15th October 2020 || Regulatory reports |
CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD ...
Regulatory report: Brazil, October 2020
Written by Marija Obradovic || 6th October 2020 || Regulatory reports |
A recent proposal in Brazil could see the legalisation of hemp cultivation for industrial purposes and cannabis for medical use. This report provides an overview of the current regulatory framework ...
Regulatory report: CBD in food – US state by state
Written by Berta Camps Bisbal || 5th October 2020 || Regulatory reports |
This report takes a state-by-state look at the status of CBD in foods in the US, detailing the current framework and status ...
Regulatory report: Japan, September 2020
Written by Lenka Hajnovicova || 17th September 2020 || Regulatory reports |
This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws ...
Regulatory report: Lithuania, August 2020
Written by CBD-Intel || 4th August 2020 || Regulatory reports |
This regulatory report provides a detailed analysis of the current regulations in place in Lithuania, as well as discussing possible future legislation that could change the legal framework ...
Regulatory report: EU narcotics law leaves question mark over future of CBD
Written by CBD-Intel || 3rd August 2020 || Regulatory reports |
Confusion over whether CBD should be considered a narcotic drug has developed into a major question mark over the substance's future in Europe ...
Regulatory report: Russia, July 2020
Written by CBD-Intel || 30th July 2020 || Regulatory reports |
Russia allows industrial hemp to be grown, but with limitations. This report provides an overview of the current regulatory regime in place for CBD and hemp in Russia ...
Regulatory report: Uruguay, July 2020
Written by Lenka Hajnovicova || 15th July 2020 || Regulatory reports |
This report offers a comprehensive overview of the regulatory regime for CBD and cannabis in Uruguay, including rules around extracts, finished products, import/export and medicinal and recreation cannabis ...
Regulatory report: Ukraine, July 2020
Written by CBD-Intel || 9th July 2020 || Regulatory reports |
The Ukrainian legal framework distinguishes between industrial hemp and cannabis. This report provides a clear analysis of the current regulatory framework for CBD and related products in Ukraine ...
Social media and the advertising of CBD: policy report
Written by Lenka Hajnovicova || 2nd July 2020 || Regulatory reports |
This report investigates the current situation with respect to advertising CBD products via the most widely used social media platforms ...
Regulatory report: Romania, June 2020
Written by Elsa Carrasco || 30th June 2020 || Regulatory reports |
Pure CBD is not a scheduled substance in Romania. This report examines the current regulatory framework for hemp and CBD in Romania, covering all aspects from import and export to medical and recreational cannabis ...
Regulatory report: Florida, June 2020
Written by Berta Camps Bisbal || 15th June 2020 || Regulatory reports |
This report provides an up-to-date analysis of the current regulatory regime for CBD and hemp-related products in the US state of Florida ...
Regulatory report: Jilin province, China
Written by CBD-Intel || 1st June 2020 || Regulatory reports |
Jilin province is the third province in China to be actively working on hemp regulation. This report offers an analysis on the potential upcoming regulations, looking at all aspects from imports to cultivation ...
Regulatory report: Hong Kong, May 2020
Written by CBD-Intel || 19th May 2020 || Regulatory reports |
This report provides an overview of the current regulatory landscape for CBD and hemp in Hong Kong, including analysis of the restrictions relating to medical and recreational cannabis ...
Regulatory report: South Korea, May 2020
Written by Marija Obradovic || 18th May 2020 || Regulatory reports |
This report offers our analysis of the regulatory regime in South Korea for CBD and related products, including extracts and finished products, their import and export, and medical and recreational cannabis ...
Regulatory report: Czech Republic, May 2020
Written by Lenka Hajnovicova || 14th May 2020 || Regulatory reports |
This report offers a thorough overview of the current regulatory regime for CBD in the Czech Republic, covering all aspects from extracts and finished products to medical and recreational cannabis ...
Regulatory report: GMP requirements for cosmetics
Written by Pablo Cano Trilla || 11th May 2020 || Regulatory reports |
This short regulatory report provides an overview of the current GMP regulations for cosmetics being place on the market in the EU ...
Regulatory report: Virginia, May 2020
Written by Berta Camps Bisbal || 7th May 2020 || Regulatory reports |
This report offers an overview of the regulatory landscape in the US state of Virginia, including information on cultivation, finished products and import/export...
Regulatory report: Oklahoma, April 2020
Written by Berta Camps Bisbal || 28th April 2020 || Regulatory reports |
This report offers an overview of the regulatory landscape in the US state of Oklahoma, including information on cultivation, finished products and import/export restrictions ...
Regulatory report: US states’ smokable hemp regulations by state, April 2020
Written by CBD-Intel || 27th April 2020 || Regulatory reports |
With the federal legalisation of hemp in the US , states were left to enact their own legislation to adapt. CBD-Intel provides an overview of US law on smokable hemp, along with analysis of each state’s rules ...
Regulatory report: Colombia, April 2020
Written by CBD-Intel || 24th April 2020 || Regulatory reports |
Cultivation of cannabis and manufacture of cannabis-derived products is permitted in Colombia under a licence. This report provides all current regulatory information in place in the country ...
Regulatory report: Mexico, April 2020
Written by Lenka Hajnovicova || 23rd April 2020 || Regulatory reports |
Cultivation and processing of hemp is currently not allowed in Mexico, however there have been recent proposals for legalisation. This report provides an overview of the current regulatory landscape, as well as likely future regulation ...
Regulatory report: Croatia, April 2020
Written by CBD-Intel || 16th April 2020 || Regulatory reports |
Pure CBD is not itself regulated under the Croatian drug regime. This report provides a detailed overview of the current regulatory framework, including finished products, extracts, medical and recreational cannabis ...
Regulatory report: Thailand legal framework for CBD still in the making
Written by CBD-Intel || 16th March 2020 || Regulatory reports |
The legal framework and licencing regime are not fully in place yet in Thailand, and the overall regulations – which affect sales, imports, exports and possession of hemp and cannabis extracts – are restrictive ...
Regulatory report: enforcement measures increase in Belgium
Written by Elsa Carrasco || 9th March 2020 || Regulatory reports |
This regulatory report covers the current situation for CBD in Belgium, looking at finished products, extracts, import and export rules and more ...
Regulatory report: hemp cultivation prohibited in Malaysia
Written by Marija Obradovic || 3rd March 2020 || Regulatory reports |
Malaysia has a tough regime on hemp products. Cultivation is prohibited because hemp falls into the cannabis legal framework. The previous government had started to look into the possibility of legalising hemp cultivation and processing ...
Regulatory report: Texas snapshot, February 2020
Written by Berta Camps Bisbal || 25th February 2020 || Regulatory reports |
The regulatory snapshot gives a comprehensive overview of the current regulatory landscape in Texas, detailing import and export laws, rules around vaping, cosmetic and pet food products as well as foodstuffs ...
Regulatory report: further hemp regulations expected soon in Peru
Written by Elsa Carrasco || 18th February 2020 || Regulatory reports |
Although CBD itself is not regulated in Peru, it is our interpretation that hemp by-products require a specific licence to be sold. This regulatory reports discusses the current rules and regulations around CBD in Peru ...
Regulatory report: CBD and hemp products – EU trademarks and patents
Written by CBD-Intel || 17th February 2020 || Regulatory reports |
This regulatory report looks at Intellectual Property law in relation to CBD and hemp products, focusing specifically on trademarks and patents and their requirements ...
Regulatory report: the path to the market for CBD foods under Article 4
Written by Pablo Cano Trilla || 13th February 2020 || Regulatory reports |
The aim of this report is to bring some clarity to the process of placing a food product on the EU market, looking at the options of Article 4 and Article 10 ...
Florida regulatory snapshot, January 2020 (update)
Written by Berta Camps Bisbal || 11th February 2020 || Regulatory reports |
This report on Florida provides updated information on our last report from the end of year, specifying updates to regulation relating to seeds, foodstuffs and pet food ...